208399-69-3

Upstream product

• 208399-66-0 4-methoxy-2-methylphenyl boronic acid 
• 208399-63-7 4-(5-[1,3]Dioxolan-2-yl-2-methoxy-phenoxy)-benzoic acid methyl ester 
• 175153-75-0 3-methoxy-4-trifluoromethane-sulfonyloxy-benzoic acid methyl ester 
• 208399-64-8 {4-[5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy]phenyl}methanol 
• 1034145-66-8 5-methoxy-2-[2-methoxy-4-(methoxycarbonyl)phenyl]benzyl bromide 
• 208399-67-1 methyl 3-methoxy-4-(4-methoxy-2-methylphenyl)benzoate 
• 109694-35-1 4-(5-diacetoxymethyl-2-methoxy-phenoxy)-3-nitro-benzoic acid methyl ester 
• 101274-71-9 4-(5-formyl-2-methoxy-phenoxy)-3-nitro-benzoic acid methyl ester 
• 101110-74-1 methyl 4-(5'-formyl-2'-methoxyphenoxy)benzoate 
• 27060-75-9 4-bromo-3-methylanisole 
• 3943-74-6 4-hydroxy-3-methoxybenzoic acid methyl ester 
• 208399-65-9 4-(5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy)benzaldehyde 

Downstream Products

• 208399-71-7 [4-(2-{4-[5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy]phenethyl}-4-methoxyphenyl)-3-methoxyphenyl]methanol 
• 208399-70-6 methyl 4-(2-{4-[5-(1,3-dioxolan-2-yl)-2-methoxyphenoxy]phenethyl}-4-methoxyphenyl)-3-methoxybenzoate 

Relevant academic research and scientific papers

Co-existence of α-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development

Liver X receptors (LXR), which were originally reported as oxysterol-activated nuclear receptors, were recently found to recognize glucose as a physiological ligand. On this basis, we have already developed novel LXR antagonists based upon α-glucosidase i

Syntheses of Cyclic Bisbibenzyl Systems

The cyclic bisbibenzyl systems Marchantin I (3), Riccardin C (4) and Isoplagiochin C (5) representing unique types of bryophyte constituents were prepared by a flexible, efficient and general synthetic approach involving the construction of biphenyl and bibenzyl units using Suzuki and Wittig protocols.